Congress Trades

REGNRegeneron Pharmaceuticals, Inc.

Healthcare · BiotechnologyNasdaqStockMkt cap $83.8B
Disclosed trades
55
0 in 30d · 0 in 90d
Politicians
14
Last trade May 15, 2026
Buys
23
$300K at range midpoints
Sells
30
$380.5K at range midpoints

Closing price · 365 days

Sep 24, 2025 – Sep 23, 2026

Monthly buys vs sells · 24 months

Counts of disclosed transactions
  • Buys
  • Sells (incl. partial)

Politicians who traded it

7 hold it now Estimated
Politicians who traded REGN
PoliticianSeatTradesBuysSellsBought (mid)Sold (mid)Last tradeEst. position Estimated
DJosh GottheimerHouse · NJ-0517710$56K$80KJan 24, 2025—
DDonald S. Beyer, Jr.House · VA-08532$24K$16KFeb 28, 2022$11.2K
DThomas R. SuozziHouse · NY-03523$107.5K$115.5KSep 16, 2019—
RTommy TubervilleSenate · AL532$24K$16KApr 4, 2024$12.7K
RByron DonaldsHouse · FL-19402$0$16KApr 10, 2025—
DJonathan L. JacksonHouse · IL-01422$40.5K$40.5KNov 13, 2024$322
DJulie JohnsonHouse · TX-32312$8K$16KApr 1, 2025—
RRobert P. Bresnahan, Jr.House · PA-08312$8K$16KMay 15, 2025$11K
DGilbert Ray Cisneros, Jr.House · CA-31211$8K$8KMay 15, 2026—
DGreg LandsmanHouse · OH-01211$8K$8KOct 15, 2024$1.6K
DMikie SherrillHouse · NJ-11202$0$16KFeb 20, 2020—
RAlan ArmstrongSenate · OK110$8K$0Mar 27, 2026$8.7K
RJefferson ShreveHouse · IN-06101$0$32.5KApr 7, 2025—
RJulia LetlowHouse · LA-05110$8K$0Feb 12, 2026$8.2K

Recent trades

Disclosed trades
PoliticianTickerAssetTypeOwnerAmountTradedFiledSource
RAlan ArmstrongREGNRegeneron Pharmaceuticals, Inc. - Common StockBuySelf$1,001 - $15,000Mar 27, 2026Jul 21, 2026116dFiling
DGilbert Ray Cisneros, Jr.REGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)SellSelf$1,001 - $15,000May 15, 2026Jun 8, 202624dFiling
RJulia LetlowREGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)BuySelf$1,001 - $15,000Feb 12, 2026Mar 12, 202628dFiling
DGilbert Ray Cisneros, Jr.REGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)BuySelf$1,001 - $15,000Nov 18, 2025Dec 15, 202527dFiling
RRobert P. Bresnahan, Jr.REGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)BuySelf$1,001 - $15,000May 15, 2025Jun 9, 202525dFiling
RByron DonaldsREGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)SellSpouse$1,001 - $15,000Apr 10, 2025May 24, 202544dFiling
RByron DonaldsREGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)SellSelf$1,001 - $15,000Apr 10, 2025May 24, 202544dFiling
DJulie JohnsonREGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)SellJoint$1,001 - $15,000Apr 1, 2025May 14, 202543dFiling
RRobert P. Bresnahan, Jr.REGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)SellSelf$1,001 - $15,000Apr 8, 2025May 8, 202530dFiling
RJefferson ShreveREGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)SellSelf$15,001 - $50,000Apr 7, 2025May 8, 202531dFiling
RRobert P. Bresnahan, Jr.REGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)SellSelf$1,001 - $15,000Feb 25, 2025Mar 27, 202530dFiling
DJulie JohnsonREGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)PartialJoint$1,001 - $15,000Feb 12, 2025Mar 12, 202528dFiling
DJulie JohnsonREGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)BuyJoint$1,001 - $15,000Jan 15, 2025Feb 12, 202528dFiling
DJosh GottheimerREGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)SellJoint$1,001 - $15,000Jan 24, 2025Feb 10, 202517dFiling
DJonathan L. JacksonREGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)SellJoint$15,001 - $50,000Nov 13, 2024Dec 12, 202429dFiling
DJonathan L. JacksonREGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)PartialJoint$1,001 - $15,000Nov 1, 2024Dec 12, 202441dFiling
DJosh GottheimerREGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)PartialJoint$1,001 - $15,000Nov 29, 2024Dec 5, 20246dFiling
DJosh GottheimerREGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)PartialJoint$1,001 - $15,000Nov 19, 2024Dec 5, 202416dFiling
DGreg LandsmanREGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)SellSpouse$1,001 - $15,000Oct 15, 2024Nov 14, 202430dFiling
RByron DonaldsREGNRegeneron Pharmaceuticals (REGN)UnknownReviewSpouse$1,001 - $15,000Oct 5, 2021Nov 8, 20241130dFilingOCR
RByron DonaldsREGNRegeneron Pharnaceuticals (REGN)UnknownReviewSelf$1,001 - $15,000Oct 5, 2021Nov 8, 20241130dFilingOCR
DJosh GottheimerREGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)PartialJoint$1,001 - $15,000Oct 23, 2024Nov 6, 202414dFiling
DJosh GottheimerREGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)PartialJoint$1,001 - $15,000Jul 1, 2024Aug 15, 202445dFiling
DGreg LandsmanREGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)BuySpouse$1,001 - $15,000Aug 11, 2023Aug 14, 2024369dFiling
RTommy TubervilleREGNRegeneron Pharmaceuticals, Inc. - Common StockSellJoint$1,001 - $15,000Apr 4, 2024May 15, 202441dFiling
DJosh GottheimerREGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)PartialJoint$1,001 - $15,000Feb 8, 2024Mar 7, 202428dFiling
DJonathan L. JacksonREGNRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)BuyJoint$1,001 - $15,000Jan 17, 2024Feb 15, 202429dFiling
DJosh GottheimerREGNRegeneron Pharmaceuticals, Inc. (REGN)PartialJoint$1,001 - $15,000Nov 13, 2023Dec 8, 202325dFiling
DJosh GottheimerREGNRegeneron Pharmaceuticals, Inc. (REGN)BuyJoint$1,001 - $15,000Aug 21, 2023Sep 16, 202326dFiling
DJosh GottheimerREGNRegeneron Pharmaceuticals, Inc. (REGN)BuyJoint$1,001 - $15,000Jul 11, 2023Aug 21, 202341dFiling
DJosh GottheimerREGNRegeneron Pharmaceuticals, Inc. (REGN)PartialJoint$1,001 - $15,000Jun 22, 2023Jul 11, 202319dFiling
DJonathan L. JacksonREGNRegeneron Pharmaceuticals, Inc. (REGN)BuyJoint$15,001 - $50,000Jun 23, 2023Jul 7, 202314dFiling
RTommy TubervilleREGNRegeneron Pharmaceuticals, Inc. - Common StockBuyJoint$1,001 - $15,000Apr 3, 2023May 12, 202339dFiling
RTommy TubervilleREGNRegeneron Pharmaceuticals, Inc. - Common StockBuyJoint$1,001 - $15,000Apr 3, 2023May 11, 202338dFiling
DJosh GottheimerREGNRegeneron Pharmaceuticals, Inc. (REGN)PartialJoint$1,001 - $15,000Mar 6, 2023Apr 20, 202345dFiling
DThomas R. SuozziREGNRegeneron Pharmaceuticals, Inc. (REGN)PartialSelf$1,001 - $15,000Aug 21, 2019Dec 19, 20221216dFiling
DJosh GottheimerREGNRegeneron Pharmaceuticals, Inc. (REGN)BuyJoint$1,001 - $15,000Oct 19, 2022Nov 10, 202222dFiling
DJosh GottheimerREGNRegeneron Pharmaceuticals, Inc. (REGN)BuyJoint$1,001 - $15,000Sep 12, 2022Oct 16, 202234dFiling
DJosh GottheimerREGNRegeneron Pharmaceuticals, Inc. (REGN)BuyJoint$1,001 - $15,000May 5, 2022Jun 16, 202242dFiling
RTommy TubervilleREGNRegeneron Pharmaceuticals, Inc. - Common StockSellJoint$1,001 - $15,000Mar 30, 2022Apr 8, 20229dFiling
DDonald S. Beyer, Jr.REGNRegeneron Pharmaceuticals, Inc. (REgN)SellJoint$1,001 - $15,000Feb 28, 2022Mar 3, 20223dFiling
DDonald S. Beyer, Jr.REGNRegeneron Pharmaceuticals, Inc. (REgN)BuyJoint$1,001 - $15,000Sep 17, 2021Oct 1, 202114dFiling
DThomas R. SuozziREGNRegeneron Pharmaceuticals, Inc. (REgN)SellSelf$50,001 - $100,000Sep 16, 2019Sep 23, 2021738dFiling
DThomas R. SuozziREGNRegeneron Pharmaceuticals, Inc. (REgN)BuySelf$50,001 - $100,000May 2, 2019Sep 23, 2021875dFiling
DThomas R. SuozziREGNRegeneron Pharmaceuticals, Inc. (REgN)SellSelf$15,001 - $50,000Nov 7, 2018Sep 23, 20211051dFiling
DThomas R. SuozziREGNRegeneron Pharmaceuticals, Inc. (REgN)BuySelf$15,001 - $50,000Nov 5, 2018Sep 23, 20211053dFiling
DJosh GottheimerREGNRegeneron Pharmaceuticals, Inc. (REGN)PartialJoint$1,001 - $15,000Jul 1, 2021Aug 9, 202139dFiling
DDonald S. Beyer, Jr.REGNRegeneron Pharmaceuticals, Inc. (REGN)BuyJoint$1,001 - $15,000Jul 21, 2021Aug 7, 202117dFiling
RTommy TubervilleREGNRegeneron Pharmaceuticals, Inc.BuyJoint$1,001 - $15,000Mar 29, 2021Jul 23, 2021116dFiling
DJosh GottheimerREGNRegeneron Pharmaceuticals, Inc. (REGN)BuyJoint$1,001 - $15,000Jan 11, 2021Feb 9, 202129dFiling

Insider activity Filed

Insiders
21
Pharmaceutical Preparations
Open-market buys · 90d
0
$0 bought
Open-market sells · 90d
6
$3.4M sold
Net · 90d
-$3.4M
-$12.9M net over 12 months · last Sep 3, 2026
Insider transactions as filed on SEC Form 4
DateInsiderKindSecuritySharesPriceValuePost-holdingsD/I10b5-1Source
Sep 3, 2026filed Sep 3, 2026Marion McCourtEVP CommercialSaleCommon Stock−1,131$857.39$969,70812,003D10b5-14
Sep 2, 2026filed Sep 3, 2026Marion McCourtEVP CommercialSaleCommon Stock−1,215$850.00$1,032,75013,134D10b5-14
Sep 2, 2026filed Sep 3, 2026Kathryn GuariniExerciseNon-Qualified Stock Option (right to buy)deriv.−400$0.00—1,158D10b5-14
Sep 2, 2026filed Sep 3, 2026Kathryn GuariniSaleCommon Stock−400$850.00$340,000603D10b5-14
Sep 2, 2026filed Sep 3, 2026Kathryn GuariniExerciseCommon Stock400$719.37$287,7481,003D10b5-14
Aug 19, 2026filed Aug 21, 2026Joseph J LarosaEVP General Counsel and SecretExerciseNon-Qualified Stock Option (right to buy)deriv.−12,282$0.00—12,283D—4
Aug 19, 2026filed Aug 21, 2026Joseph J LarosaEVP General Counsel and SecretWithholdingCommon Stock−9,019$830.15$7,487,12336,373D—4
Aug 19, 2026filed Aug 21, 2026Joseph J LarosaEVP General Counsel and SecretExerciseCommon Stock12,282$381.92$4,690,74145,392D—4
Aug 18, 2026filed Aug 20, 2026Christopher R. FenimoreEVP Finance CFOExerciseNon-Qualified Stock Option (right to buy)deriv.−6,283$0.00—6,000D—4
Aug 18, 2026filed Aug 20, 2026Christopher R. FenimoreEVP Finance CFOWithholdingCommon Stock−4,599$813.47$3,741,14919,984D—4

Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4. Net figures count open-market buys minus open-market sales only (awards, exercises, withholding and gifts are excluded).

Unusual activity Estimated